Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Peanut Allergy Market 2019-2023 - Market Forecast to Grow at a CAGR of 89.68% - ResearchAndMarkets.com

Research and Markets
Posted on: 14 Nov 18

The "Global Peanut Allergy Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The Global Peanut Allergy Market to grow at a CAGR of 89.68% during the period 2019-2023.

The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of peanut allergy across the globe.

One trend affecting this market is the business strategy framework in form of spin-offs. Spin-offs are done by companies to increase the focus on emerging businesses or for technologies that have the potential to disrupt the market. Universities and research institutes are also following this strategy to develop novel therapies to treat various indications.

According to the report, one driver influencing this market is the driven by the increase in collaborations for R&D. Drug development and marketing is an expensive and lengthy affair in the pharmaceutical industry as the peanut allergy therapy companies need extensive funding, advanced manufacturing units, and a strong distribution network. Several peanut allergy therapy companies are engaging in collaborations to gain a strong foothold on funds and skill set to develop novel peanut allergy treatment methods.

Further, the report states that one challenge affecting this market is avoiding the consumption of peanuts. The occurrence of peanut allergy is one of the rapidly increasing allergies in developed countries and is usually life-long once acquired, and the avoidance of consumption of peanuts is expected to hamper the market growth.

Key questions answered in this report

  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Market drivers

  • Increase in collaborations for R&D
  • Avoiding the consumption of peanuts
  • Business strategy framework in form of spin-offs

Key vendor

  • Aimmune Therapeutics
  • Aravax
  • DBV Technologies
  • HAL Allergy
  • Immunomic Therapeutics

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Peanut protein - Market size and forecast 2018-2023
  • Vaccine - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Aimmune Therapeutics
  • Aravax
  • DBV Technologies
  • HAL Allergy
  • Immunomic Therapeutics

PART 15: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/668557/global_peanut?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181114005510/en/

Business Wire
www.businesswire.com

Last updated on: 14/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.